Specific autoantigen of primary biliary cirrhosis (PBC) and application thereof

A technology for biliary cirrhosis and autoantigens, applied in the field of biomarkers, can solve the problems such as disputes and insufficient understanding of the role of antibodies

Inactive Publication Date: 2015-01-21
PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI +1
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The role of autoantibodies in the pathogenesis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Specific autoantigen of primary biliary cirrhosis (PBC) and application thereof
  • Specific autoantigen of primary biliary cirrhosis (PBC) and application thereof
  • Specific autoantigen of primary biliary cirrhosis (PBC) and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1 Screening of candidate PBC-related autoantigens using high-density protein chips

[0039] The high-density protein chip was provided by Professor Zhu Heng's laboratory at Johns Hopkins University. Each high-density protein chip contains 48 matrices, each of which contains 800 probes, arranged in a 32X25 array. There is one parallel spot for each protein probe on the chip, which contains 16,368 recombinant proteins. Most of the recombinant proteins are derived from the full-length ORF of the corresponding gene expressed by the Saccharomyces cerevisiae host and have a GST tag at the N-terminus (Jeong, 2012). The high-density protein chip has been disclosed in Jeong et al., Rapid Identification of Monospecific Monoclonal Antibodies Using a Human Proteome Microarray, Molecular & Cellular Proteomics (published online on February 3, 2012), and those skilled in the art can prepare accordingly.

[0040] Since the N-terminus of all protein probes on the chip is tagge...

Embodiment 2

[0067] Example 2 Construction of PBC autoantigen protein chip and verification of serum screening

[0068] Using Example 1 to screen to obtain 23 candidate PBC autoantigens and 9 PBC specific autoantibody markers known clinically or reported in the literature in recent years to prepare a PBC chip, there are 32 recombinant protein antigens planned to be expressed in the chip. However, due to some uncontrollable factors, 30 PBC-related autoantigens among them were continued to be studied in this example (Table 2).

[0069] The above 30 protein antigens were re-expressed and purified for the preparation of PBC-related antigen protein chips. image 3 -A is the lattice layout of 30 PBC-related autoantigens and control probes on a small chip. In addition to 30 PBC-related autoantigen probes, positive control probes were also included: 1) AIV-NP (avian influenza virus-Nucleoprotein, avian influenza virus nucleoprotein); 2) mouse IgG (mouse anti-human IgG antibody); 3) Human IgG and...

Embodiment 3

[0090] Example 3 ELISA verification of newly discovered autoantigens

[0091] In view of the high sensitivity and specificity of HK1 isoform I, HK1 isoform II, KLHL12, KLHL7 and ZBTB2 for the diagnosis of PBC in the chiplet results (EIF2C1 has similar detection sensitivity in PBC and SLE, 15.2% vs 15.6%), it was decided to use These newly identified autoantigens were detected by ELISA method commonly used in clinic. In addition, since HK1 isoform I and HK1 isoform II differ only in the N-terminal 21 amino acids in sequence, and the performance of the two in the small chip is basically the same, the antigens of the ELISA plate prepared here include HK1 isoform I, KLHL12, For KLHL7 and ZBTB2, the coating concentrations were 200ng / well, 75ng / well, 200ng / well and 50ng / well, respectively.

[0092] For the detection of two autoantigens, KLHL12 and ZBTB2 ( Figure 7 ). The samples tested by ELISA included 934 sera: 53 AIH patient sera, 112 HBV patient sera, 54 HCV patient sera, 87...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a specific autoantigen EIF2C1 of primary biliary cirrhosis (PBC). According to the specific autoantigen of PBC and the application thereof, six novel autoantigens of PBC are obtained through screening; during the detection on the blood serum of a PBC patient, the positive rate of each autoantigen reaches over 15%, so that the new-found autoantigens are potential biomarkers which are used for accurately diagnosing PBC through distinguishing other autoimmune diseases.

Description

[0001] This application is a divisional application of an invention application whose filing date is March 26, 2012, the Chinese application number is 201210080385.8, and the invention name is "Primary Biliary Cirrhosis Specific Autoantigen and Its Application". technical field [0002] The invention belongs to the field of biomarkers, and in particular relates to an antigen marker of primary biliary cirrhosis and its application. Background technique [0003] Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease characterized by progressive destruction of small and medium bile ducts in the liver, eventually leading to cirrhosis and liver failure (Poupon, R 2010 , Selmi, C. 2011). The pathological manifestations are inflammation in the portal area. Lymphocytes surround the damaged bile duct and infiltrate into the bile duct basement membrane and bile duct epithelial cells. This morphological feature suggests that the bile duct epithelium is the target of PB...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/47G01N33/68
CPCC07K14/47G01N33/543G01N33/6893G01N2333/47G01N2800/085
Inventor 李永哲吴琳胡朝军宋光
Owner PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap